Dr. Bryan Burt
Thoracic Surgeon & Oncologist
New York University, New York, NY
Weill Medical College of Cornell University, New York, NY
Brigham & Women’s Hospital, Boston, MA
Dr. Bryan Burt is a general thoracic surgeon and thoracic surgical oncologist at Baylor College of Medicine who currently serves as an assistant professor of surgery in the Division of General Thoracic Surgery, associate chief of General Thoracic Surgery, and director for General Thoracic Surgery Research. In addition to these positions, Dr. Burt also co-directs the Thoracic Outlet Clinic at Baylor and works alongside world-renowned mesothelioma expert Dr. David Sugarbaker at Baylor’s Mesothelioma Treatment Center.
Dr. Burt received his BA from New York University located in New York, New York. He then went on to earn his medical degree from Weill Medical College of Cornell University, also located in New York. Dr. Burt completed residencies in both general surgery and thoracic surgery at Brigham & Women’s Hospital in Boston, Massachusetts.
Clinical and Laboratory Research
Dr. Burt’s clinical practice focuses on conditions that require thoracic surgery, including, but not limited to, lung cancer, esophageal cancer, malignant pleural mesothelioma, neurogenic tumors, chest wall tumors, thymic malignancies, and thoracic outlet syndrome. Dr. Burt has stated that he feels he “can make the biggest impact through surgery.” When discussing the care he administers to his patients, Dr. Burt states he “feels privileged to care for patients with thoracic cancers and other thoracic surgical problems.” Among Dr. Burt’s highly specialized surgical skills are resectional procedures for malignant pleural mesothelioma and chest wall resection and reconstructions.
Treating patients with mesothelioma is of particular interest to Dr. Burt, and as a result, has become a key focus in some of his most recent clinical research endeavors in his laboratory. Dr. Burt is currently the principal investigator of a clinical trial exploring the administration of a checkpoint inhibitor immunotherapy prior to a surgical resection in pleural mesothelioma patients. Learn more about Dr. Burt’s innovative immunotherapy trial here.
A noted researcher and published author, Dr. Burt is a fellow of the American College of Surgeons and serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery (JTCVS). He is also a member of several professional organizations, including the Society of Thoracic Surgeons, the International Thymic Malignancy Interest Group, the American Medical Association, and the General Thoracic Biology Club. Dr. Burt is board certified by both the American Board of Surgery and the American Board of Thoracic Surgery.
Dr. Burt’s published articles relative to thoracic surgery and mesothelioma:
National Center for Biotechnology Information, U.S. National Library of Medicine—PubMed